US trial success will boost implantable defibrillators (ICD) sales
This article was originally published in Clinica
Executive Summary
Guidant and Medtronic stand to gain up to $100 million in sales of implantable defibrillators (ICDs) following the success of AVID, the federally-funded Antiarrhythmics Versus Implantable Defibrillators trial.